Sfoglia per Autore
Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No
2008 G. Finazzi, M. Gerosa, C. Chighizola, P.L. Meroni
Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases)
2008 M. Gerosa, C. Chighizola, P.L. Meroni
The interplay between the antiphospholipid syndrome and systemic lupus erythematosus
2009 A. Tincani, L. Andreoli, C. Chighizola, P. Meroni
Anti-NR2 antibodies and primary antiphospholipid syndrome : a preliminary study
2010 F. Pregnolato, M. Gerosa, C.B. Chighizola, C. Grossi, M.O. Borghi, P. Riboldi, P. Meroni
Relationship between sle susceptibility genes and clinical manifestations in a cohort of patients with primary antiphospholipid syndrome
2010 M. Fredi, L. Andreoli, C.B. Chighizola, A. Delgado Vega, C. Casu, M. Biggioggero, E. Raschi, M.O. Borghi, R. Cattaneo, P. Meroni, M. Alarcøn Riquelme, A. Tincani
Role of N-terminal pro-BNP in detecting clinically-significant cardiac involvement in systemic sclerosis patients
2010 C.B. Chighizola, B. Schreiber, P. Meroni, G. Coghlan, C.P. Denton, V. Ong
Systemic sclerosis : introduction
2011 C. B. Chighizola, Y. Shoenfeld, P. Meroni
Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons
2011 C. Chighizola, V.H. Ong, C.P. Denton
Role of anti-IFI16 antibodies and NT-proBNP as candidate biomarkers in systemic sclerosis
2012 P. Meroni, C. Chighizola, T. Schioppo, C. Artusi, V. Caneparo, M. Gariglio, R. Gualtierotti, C. Lubatti, F. Ingegnoli, S. Zeni, M. Borghi
Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients
2012 C. Chighizola, P.L. Meroni, B.E. Schreiber, J.G. Coghlan, C.P. Denton, V.H. Ong
The role of environmental estrogens and autoimmunity
2012 C. B. Chighizola, P. Meroni
Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis : "Pros" and "Cons"
2012 F. Ceccarelli, C. B. Chighizola, G. Finazzi, P. Meroni, G. Valesini
APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking
2012 D. Erkan, M. Lockshin, L. Andreoli, W. Branch, R. Brey, R. Cervera, H. Cohen, M. Cuadrado, P. deGroot, R. Derksen, P. Fortin, B. Giannakopoulos, N. Harris, M. Khamashta, S. Krilis, S.R. Levine, R. Levy, S. Machin, P. Meroni, T. Ortel, V. Pengo, S. Pierangeli, G. Pons-Estel, J. Rand, R. Roubey, J. Salmon, A. Tincani, D. Wahl, A. Banzato, C.B. Chighizola, G. de Jesus
Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis
2012 C. Chighizola, T. Schioppo, F. Ingegnoli, P. L. Meroni
Pathophysiology of the antiphospholipid syndrome (APS)
2012 P. Meroni, C. Chighizola
N-TproBNP as biomarker in systemic sclerosis
2012 T. Schioppo, C. Artusi, T. Ciavarella, F. Ingegnoli, A. Murgo, S. Zeni, C. Chighizola, P.L. Meroni
Phospholipid Autoantibodies (Non Anticardiolipin)-anti-Prothrombin Antibodies
2013 C.B. Chighizola, F. Pregnolato
Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis : a critical review of the literature
2013 L. Andreoli, C.B. Chighizola, A. Banzato, G.J. Pons Estel, G.R. De Jesus, D. Erkan
Anti-phosphatidylserine/prothrombin antibodies : an additional diagnostic marker for APS?
2013 F. Pregnolato, C. B Chighizola, S. Encabo, Z. Shums, G.L. Norman, A. Tripodi, V. Chantarangkul, T. Bertero, V. De Micheli, M.O. Borghi, P.L. Meroni
Levels of chemerin and interleukin 8 in the synovial fluid of patients with inflammatory arthritides and osteoarthritis
2014 E. Valcamonica, C.B. Chighizola, D. Comi, O. De Lucia, L. Pisoni, A. Murgo, V. Salvi, S. Sozzani, P.L. Meroni
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile